MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$21,791,037
Gain on valuation of
warrants
-$753,707
Interest income
$435,100
Loss before income
taxes
-$21,791,037
Total other income
(expense), net
$1,188,807
Loss from operations
-$22,979,844
Total operating
expenses
$22,979,844
Research and development
$11,498,761
General and
administrative
$11,481,083
Back
Back
Income Statement
source: myfinsight.com
Cellectar Biosciences, Inc. (CLRB)
Cellectar Biosciences, Inc. (CLRB)